This inventor holds 6 USPTO granted patents. Top assignees: Life Technologies Corporation, Invitrogen Corporation. Active years: 2004-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2016
Title: David Epstein: Innovator in Cell Culture Technology
Introduction
David Epstein is a notable inventor based in East Amherst, NY (US). He has made significant contributions to the field of cell culture technology, holding a total of 6 patents. His work primarily focuses on developing serum-free mammalian cell culture media, which are essential for various biotechnological applications.
Latest Patents
One of David Epstein's latest patents is titled "Serum-free mammalian cell culture medium, and uses thereof." This invention provides a cell culture medium formulation that supports the in vitro cultivation of mammalian cells, particularly epithelial and fibroblast cells. The formulation includes a basal medium and a polyanionic compound, preferably dextran sulfate. Additionally, the invention offers chemically defined, protein-free eukaryotic cell culture media that contain an iron chelate and zinc, which enhance the growth of mammalian cells in suspension culture. This innovation is crucial for increasing the expression of recombinant proteins and virus production in cultured cells.
Career Highlights
Throughout his career, David Epstein has worked with prominent companies in the biotechnology sector, including Life Technologies Corporation and Invitrogen Corporation. His expertise in cell culture technology has made him a valuable asset in these organizations, contributing to advancements in the field.
Collaborations
David has collaborated with notable professionals such as Dale F. Gruber and Stephen Gorfien. These partnerships have further enriched his work and have led to significant advancements in cell culture methodologies.
Conclusion
David Epstein's contributions to the field of cell culture technology are noteworthy, particularly his innovations in serum-free media formulations. His work continues to impact the biotechnology industry positively, enhancing the cultivation of mammalian cells for various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

